Wegovy (semaglutide) pills became available in January 2025 in 1.5 mg, 4 mg, 9 mg, and 25 mg doses. It is a medication that is FDA-approved for weight loss in individuals who meet certain criteria*, and originally was available only via injectable pen. The Wegovy pill is available with insurance coverage under specific plans and is also available via cash pay at a discount, making it more accessible to individuals without insurance coverage or those ineligible for savings programs. Wegovy pill works by activating the receptors of the glucagon-like peptide-1 (GLP-1) hormone, helping to reduce appetite and food intake, and supporting long-term weight management. Clinical studies show that patients using the Wegovy pill, along with a reduced-calorie diet and increased physical activity, achieved an average of 14% weight loss over 64 weeks. 

*BMI 30+ or 27+ with weight related medical conditions such as high blood pressure, high cholesterol, etc.

‍

Wegovy^(R) is a registered trademark of Novo Nordisk A/S.

Wegovy (semaglutide) pills are available for cash pay via Novocare Pharmacy and through commercial insurance.  In some cases, the Wegovy pill may be a more affordable option for many than the once-weekly injectable pen. Coverage and cost depend on individual insurance coverage and plan. For those without plan coverage, cash-pay prices through Novocare Pharmacy vary by dose prescribed by your physician. For questions regarding the out-of-pocket cost of the Wegoy® pill and to determine your exact financial responsibility, it is highly recommended that you contact your insurance provider directly using the member services number located on the back of your insurance card.

‍

Wegovy^(R) is a registered trademark of Novo Nordisk A/S.

The Wegovy pill is a once-daily oral medication taken by mouth. It is recommended to take the Wegovy (semaglutide) pill first thing in the morning on an empty stomach with a sip of water up to 4 ounces. Wait 30 minutes before eating, drinking, or taking other oral medications.

‍

Always follow your healthcare clinician’s instructions and consult with them on any questions. For your health and safety, please alert your prescribing clinician to any side effects you may experience. Your clinician will be able to provide personalized suggestions and make adjustments to your treatment plan. 

‍

Wegovy^(R) is a registered trademark of Novo Nordisk A/S.

The Wegovy pill aids weight loss by working in several coordinated ways within the body. It mimics a natural hormone called GLP‑1, which helps regulate appetite, satiety (the feeling of fullness), and blood sugar. By acting like GLP‑1, it influences both the brain and the digestive system to reduce overall food intake and improve metabolic function. 

‍

In the brain, Wegovy targets specific areas that help control hunger and cravings, leading to reduced appetite. This can make it easier to stick to a healthy diet and avoid overeating. Many people notice they feel satisfied with smaller portions and are less preoccupied with thoughts of food, what we call “food noise.”

‍

In the digestive system, the medication slows the rate at which the stomach empties its contents into the small intestine. Because food stays in the stomach longer, you feel fuller sooner during meals and stay full for a longer period afterward. This delayed gastric emptying helps reduce portion sizes, between‑meal snacking, and ultimately overall daily calorie intake.

‍

Wegovy also has beneficial effects on how the body handles blood sugar. It enhances the body’s sensitivity to insulin, helping cells use glucose more effectively, and it lowers the secretion of glucagon, a hormone that raises blood sugar. Together, these effects contribute to better blood sugar management, which is especially important for people with type 2 diabetes or prediabetes and supports long‑term weight management and cardiometabolic health.

‍

It’s important to talk to your clinician before starting Wegovy. Form Health does not support the use of compounded medications.

To get a prescription for Wegovy (semaglutide) pills, you must meet certain criteria. Wegovy is FDA-approved for weight loss for adults with a BMI of 30+ or 27-29.9 with at least one weight-related comorbidity, such as heart disease, obstructive sleep apnea, high cholesterol, or high blood pressure. It is to be used in combination with a reduced-calorie diet and increased physical activity. Your healthcare clinician should also take into consideration other aspects of your medical history to ensure you are a good candidate for this medication. 

‍

If eligible, your healthcare clinician will send a prescription for Wegovy pills. The Wegovy pills are available for cash pay through Novocare Pharmacy and are available via local pharmacies with insurance.

‍

Wegovy^(R) is a registered trademark of Novo Nordisk A/S.

Yes, Wegovy is the brand name for the drug semaglutide, and semaglutide is the active ingredient in the medication. Semaglutide belongs to a class of medicines called GLP‑1 receptor agonists, which mimic a natural hormone in the body that helps regulate appetite, food intake, and blood sugar.

‍

As a GLP‑1 receptor agonist, semaglutide works by activating receptors in the brain and digestive system that reduce hunger, increase feelings of fullness, and slow digestion. This combination makes it easier to eat less and maintain a lower calorie intake over time. Because of these effects, Wegovy in pill form has been approved by the FDA for chronic weight management in adults with obesity or overweight and weight‑related health conditions.

‍

Semaglutide is marketed under different brand names for specific approved uses and doses. For example, it is prescribed for the treatment of type 2 diabetes as Ozempic® (an injectable pen) and Rybelsus® (an oral tablet). Although both contain the same active ingredient, each product has distinct approved indications, dosing schedules, and administration instructions. Semaglutide should be prescribed and monitored by a healthcare professional.

‍

It’s important to be wary of advertisements for compounded semaglutide, as they are not the same as FDA-approved medications. Form Health does not support the use of compounded medications.

Wegovy can cause a range of side effects, most of which are related to the digestive system. Common gastrointestinal side effects include nausea, vomiting, diarrhea, constipation, and stomach pain or discomfort. These symptoms are often more noticeable when you first start the medication or when the dose is increased, but they frequently improve over time as your body adjusts.

‍

Other commonly reported side effects include headache, fatigue, dizziness, heartburn or indigestion, and sometimes bloating or gas. Some people may also notice decreased appetite, changes in taste, or mild injection‑site reactions if they are using the injectable form. While many of these effects are mild to moderate, they can still be uncomfortable.

‍

You should contact your doctor if you experience side effects that are bothersome, severe, or do not go away after a few weeks. Seek medical help right away if you develop symptoms such as severe abdominal pain, persistent vomiting, signs of dehydration (such as feeling very weak, dizzy, or having less urine), or symptoms of an allergic reaction like rash, swelling, or trouble breathing. Your healthcare provider may adjust your dose, suggest ways to manage symptoms, or decide whether it is safe for you to continue taking the Wegovy pill.

The Wegovy pill is available in several doses, including 1.5 mg, 4 mg, 9 mg, and 25 mg tablets. Your healthcare provider will usually start you on the lowest dose and then gradually increase it over time. This approach helps your body get used to the medication and is designed to reduce the likelihood and severity of side effects, especially gastrointestinal symptoms like nausea. The Wegovy pill is intended to be taken with just 4 oz of water 30 minutes before eating or drinking anything else, to ensure effectiveness.

‍

Typically, the dose is increased about every 30 days, as long as you are tolerating the medication well and not experiencing troublesome side effects. Your prescriber will monitor how you are feeling, how your weight and any related conditions (such as blood sugar) are responding, and then decide when and how to adjust your dose. Following the prescribed dosing schedule and not skipping or changing doses on your own is important for both safety and effectiveness.

‍

You and your healthcare provider will work together to determine the most appropriate medication titration plan for your Wegovy prescription, based on your individual needs, goals, health history, and how you respond to treatment.

The Wegovy pill is not safe or appropriate for everyone. It should not be used by people who are pregnant, planning to become pregnant, or breastfeeding, because effects in this cohort of people have not been effectively studied. People who could become pregnant are usually advised to use effective contraception while on Wegovy and to stop the medication before trying to conceive, following their prescriber’s instructions.

‍

Wegovy should also be avoided by anyone who has had a serious allergic reaction to semaglutide or any of its ingredients. Symptoms such as rash, swelling of the face or throat, severe dizziness, or trouble breathing require immediate medical attention and mean the medication should not be used again.

‍

Because of a potential risk of thyroid tumors seen in animal studies, Wegovy must not be taken by people with a personal or family history of medullary thyroid carcinoma (MTC) or those with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Before starting the Wegovy pill, discuss your full medical history with your healthcare provider, and contact them promptly to report any side effects.

The Wegovy pill and injection lead to broadly similar weight‑loss results because they use the same active ingredient (semaglutide), but they differ in how and when you take them, as well as in some practical lifestyle details.

‍

The pill is taken once daily by mouth, while the injection is given once weekly under the skin of the abdomen, thigh, or upper arm using the injection pen. The oral pill form requires a stricter routine: it must be taken daily on an empty stomach with a small amount of water, followed by a 30–60 minute wait before eating, drinking anything else, or taking other medications. This timing helps your body absorb the medicine effectively.

‍

The injection does not require any fasting or special timing with meals, which some people find more convenient. Injectable Wegovy pens usually need refrigeration before first use and have specific storage rules, whereas the pill is generally easier to travel with and store because it does not require cold storage. In choosing between the two, people often weigh their preference for daily pills vs weekly shots, their ability to follow the fasting instructions, and practical issues like travel and storage.

‍

Cost and coverage of the medication can vary depending on your insurance plan and pharmacy. The oral pill version of Wegovy may be less expensive than the injectable form, partly because it does not require a pen or specialized storage. However, insurance coverage can differ: some plans may prefer the injectable form, while others may offer better coverage or copay assistance for the pill. It’s important to review your plan’s formulary and discuss options with your provider to understand the out-of-pocket cost for each option.

Both the Wegovy pill and injection are highly effective for weight loss, as they contain the same active ingredient, semaglutide, at equivalent doses. Clinical trials have shown that they produce comparable results, with average weight loss ranging from 13% to 17% of initial body weight over 68 weeks, depending on the study population and adherence to diet and exercise.

‍

It’s important to note that medication is most effective when combined with healthy lifestyle changes, including nutrition, physical activity, and behavior change like regular sleep, and mindfulness to support sustainable habits. Working closely with your healthcare provider can help you create a personalized plan that maximizes weight loss, supports overall health, and improves long-term outcomes.